Aristeia Capital’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$331K Sell
13,443
-4,733
-26% -$109K ﹤0.01% 495
2026
Q1
$435K Buy
18,176
+6,385
+54% +$156K 0.01% 400
2025
Q4
$267K Sell
11,791
-7,521
-39% -$164K 0.01% 397
2025
Q3
$389K Buy
+19,312
New +$324K 0.01% 283
2025
Q1
Sell
-42,684
Closed -$517K 457
2024
Q4
$517K Buy
42,684
+18,903
+79% +$247K 0.02% 190
2024
Q3
$349K Buy
+23,781
New +$331K 0.01% 211

Other funds holding ELAN

Aristeia Capital's ELAN Position: Q2 2026 in Review

Aristeia Capital reduced its Elanco Animal Health (ELAN) stake by 26% in Q2 2026, selling an estimated $109K and leaving 13,443 shares worth $331K. The position accounts for ﹤0.01% of the portfolio, ranked #495.

Aristeia Capital first reported a position in ELAN in Q3 2024 and has held it in 6 quarters since. The position peaked at $517K in Q4 2024. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Aristeia Capital held 13,443 shares of Elanco Animal Health worth $331K as of Q2 2026.
  • Aristeia Capital sold 4,733 Elanco Animal Health shares in Q2 2026, an estimated $109K.
  • Elanco Animal Health made up ﹤0.01% of Aristeia Capital's portfolio in Q2 2026, its #495 holding.
  • Aristeia Capital first reported a position in Elanco Animal Health in Q3 2024 and has held it in 6 quarters since.
  • Aristeia Capital's Elanco Animal Health position peaked at $517K in Q4 2024.
  • 522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Aristeia Capital's 13F filing for Q2 2026, filed 14 Aug 2026.